Study of icodextrin levels in peritoneal dialysis patients
Part of Kidney & urinary clinical trials.
This trial studies how much of a dialysis fluid called icodextrin stays in your body after one or two doses. It is for people on long-term peritoneal dialysis who are stable and can follow a specific daily schedule.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have end-stage kidney disease and have been on peritoneal dialysis for more than 3 months.
- You are stable and can do 4 manual fluid exchanges in one day during the study.
- You cannot have a history of allergy to icodextrin or corn starch.
- You cannot have had a serious infection, heart problem, surgery, or major injury in the last month.
- You cannot have used icodextrin in the last 30 days.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a special dialysis fluid called icodextrin can help people on a low-dose form of peritoneal dialysis stay on that low dose longer before needing a full dose. It is for adults who still make some urine and can do dialysis at home.
This trial tests whether a higher or lower dose of iron works better for people on peritoneal dialysis who have low iron levels. It aims to find the best way to treat iron deficiency in this group.
This study tests a special dialysis fluid made with amino acids (protein building blocks) instead of the usual sugar-based fluid. It may help control blood sugar and improve nutrition in people with diabetes on peritoneal dialysis.
This trial compares using two doses of icodextrin (a dialysis solution) instead of one to see if it improves fluid balance and blood pressure in children on peritoneal dialysis. It may help those with high blood pressure and low urine output.
This trial studies a type of peritoneal dialysis using a special fluid called icodextrin once a day. It may help people who still make a good amount of urine to remove extra fluid more easily.
This study tests how well a continuous glucose monitor (CGM) works in people with diabetes who are also using a special dialysis fluid called icodextrin. The goal is to see if the CGM gives accurate readings while on this treatment.
Hear when a new Peritoneal Dialysis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.